Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001209191-23-050094

Chief Medical Officer acquired 1,337 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tada Hiroomi Chief Medical Officer 2023-09-15 Grant or award +1,337 $6.58 $8,796 84,467 D
Loading xslF345X05/doc4.xml…